Castration-resistant prostate cancer: [177Lu]Lu-PSMA-617 versus cabazitaxel Comment

被引：0
|
作者：
Todenhoefer, Tilman [1 ]
机构：
[1] Studienpraxis Urol, Steinengrabenstr 17, D-72622 Nurtingen, Germany
来源：
AKTUELLE UROLOGIE | 2023年 / 54卷 / 04期
关键词：
D O I：
10.1055/a-2084-8214
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617
    Hojjat Ahmadzadehfar
    Simone Wegen
    Anna Yordanova
    Rolf Fimmers
    Stefan Kürpig
    Elisabeth Eppard
    Xiao Wei
    Carl Schlenkhoff
    Stefan Hauser
    Markus Essler
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1448 - 1454
  • [22] Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617
    Ahmadzadehfar, Hojjat
    Wegen, Simone
    Yordanova, Anna
    Fimmers, Rolf
    Kuerpig, Stefan
    Eppard, Elisabeth
    Wei, Xiao
    Schlenkhoff, Carl
    Hauser, Stefan
    Essler, Markus
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1448 - 1454
  • [23] [177Lu]Lu-PSMA-617 in PSMA-positive metastatic castration-resistant prostate cancer: Prior and concomitant treatment subgroup analyses of the VISION trial.
    Vaishampayan, Nitin
    Morris, Michael J.
    Krause, Bernd J.
    Vogelzang, Nicholas J.
    Kendi, Ayse T.
    Nordquist, Luke T.
    Calais, Jeremie
    Nagarajah, James
    Beer, Tomasz M.
    El-Haddad, Ghassan
    Brackman, Marcia
    Desilvio, Michelle
    Messmann, Richard Adam
    Sartor, A. Oliver
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] [177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer
    Derlin, Thorsten
    Schmuck, Sebastian
    LANCET ONCOLOGY, 2018, 19 (08): : E372 - E372
  • [25] Urinary excretion kinetics of [177Lu]Lu-PSMA-617
    Maarten de Bakker
    Noa Dominicus
    Antoi Meeuwis
    Marcel Janssen
    Mark W. Konijnenberg
    James Nagarajah
    Steffie M. B. Peters
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3572 - 3575
  • [26] Urinary excretion kinetics of [177Lu]Lu-PSMA-617
    de Bakker, Maarten
    Dominicus, Noa
    Meeuwis, Antoi
    Janssen, Marcel
    Konijnenberg, Mark W. W.
    Nagarajah, James
    Peters, Steffie M. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (12) : 3572 - 3575
  • [27] TheraP: A randomized phase II trial of [177Lu]-PSMA-617 theranostic versus cabazitaxel in progressive metastatic castration-resistant prostate cancer
    Hofman, Michael
    Emmett, Louise
    Violet, John A.
    Lawrence, Nicola Jane
    Williams, Scott
    Stockler, Martin R.
    Francis, Roslyn J.
    Iravani, Amir
    Zhang, Alison Yan
    Martin, Andrew James
    Azad, Arun
    Yip, Sonia
    Langford, Ailsa
    McJannett, Margaret Mary
    Davis, Ian D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [28] Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer
    Anna Yordanova
    Paula Linden
    Stefan Hauser
    Michael Meisenheimer
    Stefan Kürpig
    Georg Feldmann
    Florian C. Gaertner
    Markus Essler
    Hojjat Ahmadzadehfar
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1073 - 1080
  • [29] Prognostic Tumor Markers In Men With Prostate Cancer Undergoing [177Lu]Lu-PSMA-617
    Yordanova, A.
    Linden, P.
    Hauser, S.
    Feldmann, G.
    Fimmers, R.
    Essler, M.
    Holdenrieder, S.
    Ahmadzadehfar, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S237 - S237
  • [30] Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer
    Yordanova, Anna
    Linden, Paula
    Hauser, Stefan
    Meisenheimer, Michael
    Kuerpig, Stefan
    Feldmann, Georg
    Gaertner, Florian C.
    Essler, Markus
    Ahmadzadehfar, Hojjat
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (05) : 1073 - 1080
12345